Asia-Pacific Health 2020 and Genomics without Borders: Co-Production of Knowledge by Science and Society Partnership for Global Personalized Medicine.
作者信息
Ozdemir Vural, Muljono David H, Pang Tikki, Ferguson Lynnette R, Manamperi Aresha, Samper Sofia, Someya Toshiyuki, Tassé Anne Marie, Tsai Shih-Jen, Zhou Hong-Hao, Lee Edmund J D
机构信息
Centre of Genomics and Policy, Department of Human Genetics, Faculty of Medicine, McGill University, Montreal, QC, Canada.
出版信息
Curr Pharmacogenomics Person Med. 2011 Mar 1;9(1):1-5. doi: 10.2174/187569211794728841.
Abstract
摘要
相似文献
1
Asia-Pacific Health 2020 and Genomics without Borders: Co-Production of Knowledge by Science and Society Partnership for Global Personalized Medicine.
Curr Pharmacogenomics Person Med. 2011 Mar 1;9(1):1-5. doi: 10.2174/187569211794728841.
2
Bernard Lerer: recipient of the 2014 inaugural Werner Kalow Responsible Innovation Prize in Global Omics and Personalized Medicine (Pacific Rim Association for Clinical Pharmacogenetics).
OMICS. 2014 Apr;18(4):211-21. doi: 10.1089/omi.2014.0029. Epub 2014 Mar 20.
3
Advances in translational bioinformatics and population genomics in the Asia-Pacific.
BMC Genomics. 2012;13 Suppl 7(Suppl 7):S1. doi: 10.1186/1471-2164-13-S7-S1. Epub 2012 Dec 13.
4
Genomic Medicine Without Borders: Which Strategies Should Developing Countries Employ to Invest in Precision Medicine? A New "Fast-Second Winner" Strategy.
OMICS. 2017 Nov;21(11):647-657. doi: 10.1089/omi.2017.0141.
5
Equity should know no borders: The role of Australasian radiation oncologists in supporting radiation oncology services in low- and middle-income countries in the Asia-Pacific.
J Med Imaging Radiat Oncol. 2021 Jul;65(4):410-417. doi: 10.1111/1754-9485.13191. Epub 2021 May 10.
6
Drug production, trafficking and trade in Asia and Pacific Island countries.
Drug Alcohol Rev. 2006 Nov;25(6):647-50. doi: 10.1080/09595230600972850.
7
Promoting synergistic research and education in genomics and bioinformatics.
BMC Genomics. 2008;9 Suppl 1(Suppl 1):I1. doi: 10.1186/1471-2164-9-S1-I1.
8
Personalized Medicine Across Disciplines and without Borders. Vural Özdemir speaks to Hannah Wilson, Commissioning Editor.
Per Med. 2014;11(7):687-691. doi: 10.2217/pme.14.70.
9
Towards big data science in the decade ahead from ten years of InCoB and the 1st ISCB-Asia Joint Conference.
BMC Bioinformatics. 2011;12 Suppl 13(Suppl 13):S1. doi: 10.1186/1471-2105-12-S13-S1. Epub 2011 Nov 30.
10
The Asia Pacific Academic Consortium for Global Public Health and medicine: stabilizing south-south academic collaboration.
Infect Dis Clin North Am. 2011 Sep;25(3):537-54, viii. doi: 10.1016/j.idc.2011.05.005.
引用本文的文献
1
Co-Design as Enabling Factor for Patient-Centred Healthcare: A Bibliometric Literature Review.
Clinicoecon Outcomes Res. 2023 May 17;15:333-347. doi: 10.2147/CEOR.S403243. eCollection 2023.
2
Genomic translational research: Paving the way to individualized cardiac functional analyses and personalized cardiology.
Int J Cardiol. 2017 Mar 1;230:384-401. doi: 10.1016/j.ijcard.2016.12.097. Epub 2016 Dec 21.
3
All the post-genomic world is a stage: the actors and narrators required for translating pharmacogenomics into public health.
Per Med. 2013 May 1;10(3):213-216. doi: 10.2217/pme.13.10.
4
Personalizing health care: feasibility and future implications.
BMC Med. 2013 Aug 13;11:179. doi: 10.1186/1741-7015-11-179.
5
Pharmacogenomics in Primary Care: A Crucial Entry Point for Global Personalized Medicine?
Curr Pharmacogenomics Person Med. 2012;10(2):101-105. doi: 10.2174/187569212800626430.
6
End of the Beginning and Public Health Pharmacogenomics: Knowledge in 'Mode 2' and P5 Medicine.
Curr Pharmacogenomics Person Med. 2012 Jan 1;10(1):1-6. doi: 10.2174/1875692111201010001.
7
Towards an Ecology of Collective Innovation: Human Variome Project (HVP), Rare Disease Consortium for Autosomal Loci (RaDiCAL) and Data-Enabled Life Sciences Alliance (DELSA).
Curr Pharmacogenomics Person Med. 2011 Dec 1;9(4):243-251. doi: 10.2174/187569211798377153.
8
Forward Look: Tenth Anniversary of the Human Genome Sequence and 21 Century Postgenomics Global Health - A Close Up on Africa and Women's Health.
Curr Pharmacogenomics Person Med. 2011 Sep 1;9(3):148-155. doi: 10.2174/187569211796957511.
9
Personalized Medicine in the Age of Pharmacoproteomics: A Close up on India and Need for Social Science Engagement for Responsible Innovation in Post-Proteomic Biology.
Curr Pharmacogenomics Person Med. 2011 Mar 1;9(1):67-75. doi: 10.2174/187569211794728850.
本文引用的文献
1
Nutriproteomics and Proteogenomics: Cultivating Two Novel Hybrid Fields of Personalized Medicine with Added Societal Value.
Curr Pharmacogenomics Person Med. 2010 Dec 1;8(4):240-244. doi: 10.2174/187569210793368230.
2
Ethnogeographical structure of hepatitis B virus genotype distribution in Indonesia and discovery of a new subgenotype, B9.
Arch Virol. 2011 May;156(5):855-68. doi: 10.1007/s00705-011-0926-y. Epub 2011 Feb 12.
3
Nutrigenomics in human intervention studies: current status, lessons learned and future perspectives.
Mol Nutr Food Res. 2011 Mar;55(3):341-58. doi: 10.1002/mnfr.201000512. Epub 2011 Jan 31.
4
Health biotechnology innovation on a global stage.
Nat Rev Microbiol. 2011 Feb;9(2):137-43. doi: 10.1038/nrmicro2492.
5
Germs, genomics and global public health: How can advances in genomic sciences be integrated into public health in the developing world to deal with infectious diseases?
Hugo J. 2009 Dec;3(1-4):5-9. doi: 10.1007/s11568-009-9131-4. Epub 2009 Nov 5.
6
Responsible innovation: a pilot study with the U.K. Engineering and Physical Sciences Research Council.
Risk Anal. 2010 Nov;30(11):1699-707. doi: 10.1111/j.1539-6924.2010.01517.x.
7
The new age of global health governance holds promise.
Nat Med. 2010 Nov;16(11):1181. doi: 10.1038/nm1110-1181.
8
Research funding. Sustaining the data and bioresource commons.
Science. 2010 Oct 29;330(6004):592-3. doi: 10.1126/science.1191506.
9
Meeting report: fourth Asia-Pacific nutrigenomics conference: gene-diet interactions in gut health, Auckland, New Zealand, February 21-25, 2010.
Biotechnol J. 2010 Sep;5(9):913-8. doi: 10.1002/biot.201000074.
10
Quality, quantity and harmony: the DataSHaPER approach to integrating data across bioclinical studies.
Int J Epidemiol. 2010 Oct;39(5):1383-93. doi: 10.1093/ije/dyq139. Epub 2010 Sep 2.
Zotero 插件